GAM
COLL icon

Gemmer Asset Management’s Collegium Pharmaceutical COLL Stock Holding History

Gemmer Asset Management’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-100
Closed -$1K – 1247
2017
Q2 		$1K Hold
100
– – ﹤0.01% 1211
2017
Q1 		$1K Hold
100
– – ﹤0.01% 1204
2016
Q4 		$2K Hold
100
– – ﹤0.01% 1151
2016
Q3 		$2K Hold
100
– – ﹤0.01% 1159
2016
Q2 		$1K Hold
100
– – ﹤0.01% 1201
2016
Q1 		$1K Hold
100
– – ﹤0.01% 1174
2015
Q4 		$3K Hold
100
– – ﹤0.01% 974
2015
Q3 		$2K Hold
100
– – ﹤0.01% 1073
2015
Q2 		$2K Buy
+100
New +$1.73K ﹤0.01% 1124

Other funds holding COLL

Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
CCM
Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Gemmer Asset Management's COLL Position: Q3 2017 in Review

Gemmer Asset Management sold out of Collegium Pharmaceutical (COLL) in Q3 2017, closing a stake of 100 shares — an estimated $1K sold.

Gemmer Asset Management first reported a position in COLL in Q2 2015 and held it in 9 quarters. The position peaked at $3K in Q4 2015. 75 funds tracked by Wall St. Rank hold COLL as of Q3 2017.

  • Gemmer Asset Management reported no remaining Collegium Pharmaceutical position as of Q3 2017 after selling out during the quarter.
  • Gemmer Asset Management sold 100 Collegium Pharmaceutical shares in Q3 2017, an estimated $1K.
  • Gemmer Asset Management first reported a position in Collegium Pharmaceutical in Q2 2015 and held it in 9 quarters.
  • Gemmer Asset Management's Collegium Pharmaceutical position peaked at $3K in Q4 2015.
  • 75 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q3 2017.

Based on Gemmer Asset Management's 13F filing for Q3 2017, filed 12 Oct 2017.